Results 131 to 140 of about 359,969 (268)
MedComm, Volume 7, Issue 11, November 2026.Prostate tumors from six heterozygous G84E variant carriers (G84E positive) and 18 non‐carriers (wild‐type) were examined using the Human AmpliSeq Transcriptome Gene Expression Panel, and proteomes were generated by mass spectrometry (SWATH). We identified a 799‐gene expression profile and a 75‐protein expression profile in G84E‐positive tumors when ...
Kelsie Raspin +13 more
wiley +1 more source
Neurourology and Urodynamics, Volume 45, Issue 8, Page 1692-1700, November 2026.ABSTRACT Aims To evaluate the prevalence, clinical course, and risk factors of lower urinary tract symptoms (LUTS) in patients hospitalized with COVID‐19, and to assess associations with comorbidities, disease severity, and vaccination status. Methods We conducted a prospective cohort study of adult patients hospitalized with confirmed COVID‐19, who ...
Julia Duarte de Souza +12 more
wiley +1 more source
Giant Benign Prostatic Hyperplasia (GBPH): Case report from a Tertiary Hospital in Eldoret, Kenya
, 2020 Benign growth of the prostate is the commonest prostatic problem of the aging male, but the giant version of benign prostatic hyperplasia has been reported as a rare occurrence.
Musau, P., Omondi, M.
core
Neurourology and Urodynamics, Volume 45, Issue 8, Page 1630-1642, November 2026.ABSTRACT Aims Urinary incontinence (UI) is a prevalent condition among adults and imposes a substantial societal burden, yet its association with all‐cause mortality remains uncertain. This study systematically reviewed and quantified the association between UI and mortality risk.
Yanyan Zhou +6 more
wiley +1 more source
Neurourology and Urodynamics, Volume 45, Issue 8, Page 1500-1506, November 2026.ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang +2 more
wiley +1 more source
Armaghane Danesh Bimonthly Journal, 2009 : Introduction & Objective: Results of different studies show that a relatively large number of healthcare services offered are inappropriate or unnecessary. Benign prostatic hyperplasia is a benign enlargement of the prostate gland.
R Ostovar +7 more
doaj
Urodynamic Voiding Patterns in Multiple Sclerosis
Neurourology and Urodynamics, Volume 45, Issue 8, Page 1569-1577, November 2026.ABSTRACT Aims This study aimed to describe urodynamic voiding patterns in patients with MS (PwMS) using standardized assessments, and to compare the performance of the available nomograms and indices for obstruction and bladder contractility. Methods PwMS and lower urinary tract symptoms underwent cystometry and pressure flow studies.
Camille Chesnel +5 more
wiley +1 more source
Management and Treatment of Benign Prostatic Hyperplasia Symptoms: Current Insights [PDF]
Othmane Zekraoui,1 Naeem Bhojani,1,2 Kevin C Zorn,3 Dean Elterman,4 Bilal Chughtai5,6 1Faculty of Medicine, Université de Montréal, Montreal, QC, Canada; 2Division of Urology, Department of Surgery, Université de Montréal Health Center, Montreal, QC ...
Zorn KC +4 more
core
Primary BPH Stromal Cell Cultures Exhibit Heightened Androgen‐Responsiveness
The Prostate, Volume 86, Issue 15, Page 1508-1517, November 2026.ABSTRACT Background Benign prostatic hyperplasia (BPH) is the most common disease in aging males. BPH growth is androgen‐dependent, and it appears that androgens preferentially stimulate the growth of BPH as compared to normal prostate. The mechanism of preferential androgen stimulation of BPH growth is not clear.
Wei Chen +9 more
wiley +1 more source
Treatment of benign prostatic hyperplasia [PDF]
Revista da Associação Médica Brasileira, 2017 Ricardo Vita, Nunes +5 more
openaire +2 more sources